-
Mashup Score: 1
Thieme E-Books & E-Journals
Source: www.thieme-connect.comCategories: General Medicine News, NeurologyTweet
-
Mashup Score: 2Surgery, Needle Fasciotomy, or Collagenase Injection for Dupuytren Contracture: A Randomized Controlled Trial: Annals of Internal Medicine: Vol 0, No 0 - 3 month(s) ago
Background: Surgery, needle fasciotomy, and collagenase injection are used to treat Dupuytren contracture. The treatment decision requires balancing initial morbidity and costs of surgery against its potential long-term benefits over needle fasciotomy and collagenase. Objective: To compare the effectiveness of surgery, needle fasciotomy, and collagenase injection at 3 months and 2 years (secondary time points of the trial). Design: A multicenter, randomized, outcome assessor–blinded, superiority trial. (ClinicalTrials.gov: NCT03192020) Setting: 6 public hospitals in Finland. Participants: 302 persons with treatment-naive Dupuytren contracture (contracture angle <135°). Intervention: Surgery (n = 101), needle fasciotomy (n = 101), or collagenase (n = 100). Measurements: The primary outcome was the success rate, defined as greater than 50% contracture release and patients reaching the patient acceptable symptom state. Secondary outcomes included hand function, pain, quality of life, pati
Source: www.acpjournals.orgCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 3Surgery, Needle Fasciotomy, or Collagenase Injection for Dupuytren Contracture: A Randomized Controlled Trial: Annals of Internal Medicine: Vol 0, No 0 - 3 month(s) ago
Background: Surgery, needle fasciotomy, and collagenase injection are used to treat Dupuytren contracture. The treatment decision requires balancing initial morbidity and costs of surgery against its potential long-term benefits over needle fasciotomy and collagenase. Objective: To compare the effectiveness of surgery, needle fasciotomy, and collagenase injection at 3 months and 2 years (secondary time points of the trial). Design: A multicenter, randomized, outcome assessor–blinded, superiority trial. (ClinicalTrials.gov: NCT03192020) Setting: 6 public hospitals in Finland. Participants: 302 persons with treatment-naive Dupuytren contracture (contracture angle <135°). Intervention: Surgery (n = 101), needle fasciotomy (n = 101), or collagenase (n = 100). Measurements: The primary outcome was the success rate, defined as greater than 50% contracture release and patients reaching the patient acceptable symptom state. Secondary outcomes included hand function, pain, quality of life, pati
Source: www.acpjournals.orgCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0James Woody, MD, PhD: Anti-TNF for Dupuytren’s Disease Treatment - 2 year(s) ago
James Woody, MD, PhD, explains the benefits of treating Dupuytren’s disease with anti-tumor necrosis factor (TNF).
Source: Rheumatology NetworkCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 1#JHSJC – JHS Focus - 2 year(s) ago
JHS Journal Club Created in 2018, the JHS Journal Club is a Twitter-based journal club that allows you to interact with other Journal of Hand Surgery readers and discuss interesting articles in JHS. You’ll participate in live meetings via Twitter, sharing thoughts with readers from around the world. **As of January 2022, we will no longer be using our former…
Source: jhsfocus.orgCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0#JHSJC – JHS Focus - 2 year(s) ago
JHS Journal Club Created in 2018, the JHS Journal Club is a Twitter-based journal club that allows you to interact with other Journal of Hand Surgery readers and discuss interesting articles in JHS. You’ll participate in live meetings via Twitter, sharing thoughts with readers from around the world. **As of January 2022, we will no longer be using our former…
Source: jhsfocus.orgCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 2#JHSJC – JHS Focus - 2 year(s) ago
JHS Journal Club Created in 2018, the JHS Journal Club is a Twitter-based journal club that allows you to interact with other Journal of Hand Surgery readers and discuss interesting articles in JHS. You’ll participate in live meetings via Twitter, sharing thoughts with readers from around the world. **As of January 2022, we will no longer be using our former…
Source: jhsfocus.orgCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0#JHSJC – JHS Focus - 2 year(s) ago
JHS Journal Club Created in 2018, the JHS Journal Club is a Twitter-based journal club that allows you to interact with other Journal of Hand Surgery readers and discuss interesting articles in JHS. You’ll participate in live meetings via Twitter, sharing thoughts with readers from around the world. **As of January 2022, we will no longer be using our former…
Source: jhsfocus.orgCategories: Latest Headlines, RheumatologyTweet-
March's #JHSJC is TOMORROW @ 9pm ET! We'll discuss 1) 5-yr results of a RCT comparing #collagenase treatment & #NeedleFasciotomy for #Dupuytren contracture and 2) simple decompression outcome of primary #CubitalTunnelSyndrome based on #PROMs. More info: https://t.co/SOZ8a61PTV https://t.co/pJItwSxSqI
-
-
Mashup Score: 0Does Use of a Night Extension Orthosis Improve Outcomes in Patients With Dupuytren Contracture Treated With Injectable Collagenase? - 2 year(s) ago
Current prescribing information for the treatment of patients with Dupuytren contracture with injectable collagenase Clostridium histolyticum (CCH) recommends use of a night extension orthosis for 4 months after treatment. The present study examines whether this treatment improves the outcomes.
Categories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 1Does Use of a Night Extension Orthosis Improve Outcomes in Patients With Dupuytren Contracture Treated With Injectable Collagenase? - 2 year(s) ago
Current prescribing information for the treatment of patients with Dupuytren contracture with injectable collagenase Clostridium histolyticum (CCH) recommends use of a night extension orthosis for 4 months after treatment. The present study examines whether this treatment improves the outcomes.
Categories: Latest Headlines, RheumatologyTweet
RT @ThiemePlasticS: Original Article #Dupuytren's Disease: A Novel Minimally Invasive Pull-Through Technique https://t.co/lX7VdYga0E #plast…